The company isn't wasting any time drafting seasoned professionals to help it develop medication for a rare genetic disorder.
Bright Minds Biosciences ( ($TSE:DRUG) ) just unveiled an update. Bright Minds Biosciences has expanded its Scientific Advisory Board by adding ...
The live and archived webcast for the Cantor event will be accessible from the Company’s website at https://brightmindsbio.com/investors/ under Events and ...
Columbus, OH - August 29, 2007 - Brighter Minds Media, LLC in conjunction with Universal Pictures Digital Platforms Group, announces the release of Jurassic Park Explorer, a new DVD game based on the ...
Bright Minds is focused on developing novel transformative treatments for neuropsychiatric disorders, epilepsy, and pain. Bright Minds has a portfolio of next-generation serotonin agonists designed to ...
COLUMBUS, OH – August 24, 2010 – Brighter Minds is proud to announce three unique apps for the incredible Apple iPad. The newly released apps, which can be found through iTunes and through the iPad’s ...
NEW YORK, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Bright Minds Biosciences, Inc. (“Bright Minds,” “BMB” or the “Company”) (NASDAQ: DRUG), a pioneering company focused on developing highly selective 5-HT2 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback